Physician profile

Mark D Fish

Orthopaedic Surgery · Clive, IA

NPI 1548212368

$25,322.37

in general payments reported to CMS, 2019-2025

14 companies · $538 in 2025

The $538 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).

Payments by year

General and research payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,732.35
Education$381.58

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Maxx Orthopedics, INC. $11,072.56 2019-2024
Wardlow Enterprises $4,472.71 2019-2023
Zimmer Biomet Holdings, INC. $3,066.87 2019-2025 Comprehensive Shoulder System, Oxford, Persona
Arthrex, INC. $2,414.16 2019-2022
Smith+Nephew, INC. $1,779.81 2019-2024 Real Intelligence
Medwest Associates $1,211.51 2022
Stryker Corporation $645.49 2019-2024 Triathlon, Mako, Reunion
Prism Medical $302.05 2024-2025
Exactech, INC. $102.62 2023
Maxx Health INC $82.50 2023 Summa Ortho Fibula Plate
Kerecis Limited $53.81 2025 Kerecis Surgiclose, Kerecis Graftguide
Depuy Synthes Sales INC. $43.45 2019-2024 Monovisc, Orthovisc
Pacira Pharmaceuticals Incorporated $43.12 2023 Iovera
Heron Therapeutics, INC. $31.71 2021-2024 Zynrelef

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$1,750.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Mark D Fish

$25,322.37

in general payments reported 2019-2025

Years
2019-2025
Top company
Maxx Orthopedics, INC.
Context
The $538 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).

https://glasscript.com/doctor/114928/mark-d-fish

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.